Trial Updates

The future of Alzheimer’s disease: aducanumab 2:38
The future of Alzheimer’s disease: aducanumab
John Hardy • 20 Oct 2020
Successes in Parkinson’s disease: seeding assays and neurofilament light chains 3:19
Successes in Parkinson’s disease: seeding assays and neurofilament light chains
Brit Mollenhauer • 4 Sep 2020
Developments in Parkinson’s disease research and PASADENA clinical trial update 3:21
Developments in Parkinson’s disease research and PASADENA clinical trial update
Tiago Outeiro • 18 Sep 2020
Beneficial effects of aerobic exercise in slowing Parkinson’s disease progression 4:09
Beneficial effects of aerobic exercise in slowing Parkinson’s disease progression
Terry Ellis • 14 Sep 2020
Appraisal of Huntington’s disease clinical trials 2:50
Appraisal of Huntington’s disease clinical trials
Joaquim Ferreira • 4 Sep 2020
The 4 Repeat Tauopathy Neuroimaging Initiative 2:00
The 4 Repeat Tauopathy Neuroimaging Initiative
Adam Boxer • 9 Sep 2020
The problems arising in ASO clinical trials and future preparations 3:38
The problems arising in ASO clinical trials and future preparations
Joaquim Ferreira • 4 Sep 2020
Opicapone shows better motor performance in Parkinson’s disease compared to entacapone 3:37
Opicapone shows better motor performance in Parkinson’s disease compared to entacapone
Joaquim Ferreira • 4 Sep 2020
ASO tominersen for Huntington’s disease in Phase III trials 2:20
ASO tominersen for Huntington’s disease in Phase III trials
Edward Wild • 4 Sep 2020
Personalized medicine in Parkinson’s disease 2:26
Personalized medicine in Parkinson’s disease
Oscar Gershanik • 4 Sep 2020
CGRP monoclonal antibodies & migraine management during COVID-19 pandemic 20:54
CGRP monoclonal antibodies & migraine management during COVID-19 pandemic
Stewart Tepper • 24 May 2020
Benefit of migraine prevention with erenumab 19:11
Benefit of migraine prevention with erenumab
Stewart Tepper • 24 May 2020
Pediatric MS: where does research need to move? 1:08
Pediatric MS: where does research need to move?
Tanuja Chitnis • 24 May 2020
The evolving landscape of migraine treatment and prevention 3:42
The evolving landscape of migraine treatment and prevention
Uwe Reuter • 22 May 2020
PROMISE-1: eptinezumab in episodic migraine 2:44
PROMISE-1: eptinezumab in episodic migraine
Messoud Ashina • 29 May 2020
Fremanezumab in patients with chronic or episodic migraine 2:52
Fremanezumab in patients with chronic or episodic migraine
Uwe Reuter • 22 May 2020
The content of VJNeurology is intended for healthcare professionals